These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2519816)

  • 1. [Levels erythrocyte and plasma magnesium in patients in chronic dialysis].
    García-Ortiz R; Milovic I; Uribe C; Gómez M
    Rev Med Chil; 1989 May; 117(5):544-8. PubMed ID: 2519816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and erythrocyte magnesium levels in patients with chronic renal failure.
    Głuszek J
    Pol Med Sci Hist Bull (1973); 1976; 15-16(4):353-8. PubMed ID: 1005219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hypermagnesemia on circulating plasma parathyroid hormone in patients on regular hemodialysis therapy.
    McGonigle RJ; Weston MJ; Keenan J; Jackson DB; Parsons V
    Magnesium; 1984; 3(1):1-7. PubMed ID: 6482508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J; Piecha G; Kokot F; Wiecek A
    J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc and copper concentration in plasma and erythrocytes of patients with chronic renal failure.
    Paniagua-Sierra JR; Pérez-López A; Diaz-Bensussen S; Solís-Alpuche L; Saavedra-Guatemala H; Exaire-Murad JE
    Arch Invest Med (Mex); 1981; 12(1):69-82. PubMed ID: 7247613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of serum ionized versus total levels of magnesium and calcium in hemodialysis patients.
    Saha H; Harmoinen A; Pietilä K; Mörsky P; Pasternack A
    Clin Nephrol; 1996 Nov; 46(5):326-31. PubMed ID: 8953122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum osteoprotegerin level is lower in peritoneal dialysis patients than in hemodialysis ones.
    Grzegorzewska AE; Młot M
    Rocz Akad Med Bialymst; 2004; 49():193-6. PubMed ID: 15631342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.
    Markell MS; Altura BT; Sarn Y; Delano BG; Ifudu O; Friedman EA; Altura BM
    ASAIO J; 1993; 39(3):M801-4. PubMed ID: 8268649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of an erythrocyte aluminum assay in the diagnosis of aluminum-associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy.
    Abreo K; Brown ST; Sella M; Trapp G
    J Lab Clin Med; 1989 Jan; 113(1):50-7. PubMed ID: 2909650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kinetics of potassium transfer during hemodialysis].
    Bulliard C; Guignard JP; Ruiz J; Moret H; Fellay G
    Nephrologie; 2001; 22(1):15-9. PubMed ID: 11280036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trace elements in patients on chronic hemodialysis. 2. Plasma magnesium.
    Shirai T; Imori H; Konomi G; Nakao M; Minoda H; Ikuta T
    Fukuoka Shika Daigaku Gakkai Zasshi; 1989; 16(1):11-8. PubMed ID: 2632286
    [No Abstract]   [Full Text] [Related]  

  • 15. [Content of thiamin in plasma and erythrocytes in patients with end stage renal disease].
    Pietrzak I; Baczyk K; Młynarczyk M; Kaczmarek M
    Przegl Lek; 1996; 53(5):423-6. PubMed ID: 8754406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and red blood cell magnesium levels and plasma creatinine after a 100 km race.
    Rama R; Ibáñez J; Pagés T; Callis A; Palacios L
    Rev Esp Fisiol; 1993 Mar; 49(1):43-7. PubMed ID: 8378576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The impact of changes in levels of calcium, phosphate and magnesium during hemodialysis on autonomic system reactivity as measured by heart rate variability analysis].
    Buda S; Stompór T; Sułowicz W; Kopeć J; Szymczakiewicz-Multanowska A; Janion M
    Przegl Lek; 2000; 57(6):340-5. PubMed ID: 11107869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole blood-, plasma- and red blood cell glutathione and cysteine in patients with kidney disease and during hemodialysis.
    Jacobson SH; Moldéus P
    Clin Nephrol; 1994 Sep; 42(3):189-92. PubMed ID: 7994938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.